Skip to main content
CLColgate-Palmolive CompanySell5.4·$89.59+0.22%
Open full analysis

Colgate-Palmolive Company (CL) Stock Analysis

Range Bound setup

SellVALUE-TRAP 1/5High Confidence

Consumer Defensive · Household & Personal Products

Sell if holding. Analyst target reached at $89.59 — A.R:R is negative (-0.6) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 16.4): -1.5.

Colgate-Palmolive markets oral, personal, home care, and pet nutrition products across 200+ countries, with Oral Care (Colgate, elmex, Tom's of Maine) at 44% and Pet Nutrition (Hill's) at 23% of 2025 net sales. Walmart represented approximately 11% of net sales in 2025, the only... Read more

$89.59+1.1% A.UpsideScore 5.4/10#7 of 13 Household & Personal Products
QualityF-score6 / 9FCF yield4.64%
IncomeYield2.37%(5y avg 2.32%)Payout80.62%at-risk
Stop $84.53Target $90.44(resistance)A.R:R -0.6:1
Analyst target$95.85+7.0%20 analysts
$90.44our TP
$89.59price
$95.85mean
$80
$105

Sell if holding. Analyst target reached at $89.59 — A.R:R is negative (-0.6) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 16.4): -1.5. Chart setup: RSI 47 mid-range, Bollinger mid-band. Score 5.4/10, high confidence.

Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 48d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and 8k serious 2.05. Suitability: conservative.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-13
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Fri, Jul 31, 202648d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
High-quality business
Risks
Analyst target reached - limited upside remaining
Leverage penalty (D/E 16.4): -1.5
Weak growth

Key Metrics

P/E (TTM)34.7
P/E (Fwd)22.1
Mkt Cap$71.6B
EV/EBITDA15.9
Profit Mgn10.0%
ROE363.6%
Rev Growth8.4%
Beta0.32
Dividend2.37%
Rating analysts30

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C0.54bullish
IV34%normal
Max Pain$140+56.3% vs spot

Concentration Risks(10-K Item 1A)

  • LOWCustomerWalmart11%
    10-K Item 1: 'Our sales to Walmart, Inc. and its affiliates represented approximately 11% of our Net sales in 2025.'
  • MEDIUMProductOral Care44%
    10-K Item 1: 'Sales of Oral, Personal and Home Care products accounted for 44%, 17% and 16%, respectively, of our total worldwide Net sales in 2025.'
  • MEDIUMSuppliersingle-source suppliers
    10-K Item 1: 'We do, however, purchase certain key raw and packaging materials from single-source suppliers or a limited number of suppliers'

Material Events(8-K, last 90d)

  • 2026-05-01Item 2.05MEDIUM
    Update on Strategic Growth and Productivity Program (Board-approved July 31, 2025): three-year initiative to realign organizational structure in support of 2030 strategy. Filing discloses costs associated with exit or disposal activities; specific charge amount truncated in available excerpt.
    SEC filing →
  • 2026-04-09Item 5.02MEDIUM
    Jennifer M. Daniels (CLO and Secretary since 2014) announced retirement in 2026. Betsy Fishbone (EVP and Deputy CLO) elected CLO and Secretary effective June 1, 2026; Daniels transitions to Vice Chair for orderly handoff.
    SEC filing →
  • 2026-03-12Item 5.02LOW
    Christopher S. Boerner, Ph.D. (CEO and Board Chair of Bristol-Myers Squibb) elected to Colgate-Palmolive Board, effective March 15, 2026. Board appointment only; no officer change.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.8
Revenue Growth
4.6
GatesA.R:R -0.6=NEGATIVE8K SERIOUS 2.05Momentum 5.8>=5.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 48d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Conservative
RSI
47 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $84.30Resistance $92.29

Price Targets

$85
$90
A.Upside+0.9%
A.R:R-0.6:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-3.6% upside)
! Negative risk/reward — downside exceeds upside
! 8K_SERIOUS:2.05

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-31 (48d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CL stock a buy right now?

Sell if holding. Analyst target reached at $89.59 — A.R:R is negative (-0.6) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 16.4): -1.5. Chart setup: RSI 47 mid-range, Bollinger mid-band. Prior stop was $84.53. Score 5.4/10, high confidence.

What is the CL stock price target?

Take-profit target: $90.44 (+1.1% upside). Prior stop was $84.53. Stop-loss: $84.53.

What are the risks of investing in CL?

Analyst target reached - limited upside remaining; Leverage penalty (D/E 16.4): -1.5; Weak growth.

Is CL overvalued or undervalued?

Colgate-Palmolive Company trades at a P/E of 34.7 (forward 22.1). TrendMatrix value score: 4.8/10. Verdict: Sell.

What do analysts say about CL?

30 analysts cover CL with a consensus score of 3.8/5. Average price target: $96.

What does Colgate-Palmolive Company do?Colgate-Palmolive markets oral, personal, home care, and pet nutrition products across 200+ countries, with Oral Care...

Colgate-Palmolive markets oral, personal, home care, and pet nutrition products across 200+ countries, with Oral Care (Colgate, elmex, Tom's of Maine) at 44% and Pet Nutrition (Hill's) at 23% of 2025 net sales. Walmart represented approximately 11% of net sales in 2025, the only disclosed customer above 10%; two-thirds of revenues originate outside the United States. The company employs approximately 33,600 people across more than 100 countries.

Related stocks: KVUE (Kenvue Inc.) · UL (Unilever PLC) · PG (Procter & Gamble Company (The)) · KMB (Kimberly-Clark Corporation) · CHD (Church & Dwight Company, Inc.)
Home Stocks CL

Latest news

Latest News

TipRanks47d ago
MarketBeat47d ago
The Globe and Mail48d ago
MarketWatch48d ago
MarketBeat48d ago
MarketBeat49d ago
StockStory47d agoEarnings
Insider Monkey53d agoAnalyst
MarketBeat54d ago
Investor's Business Daily54d ago
IndexBox51d ago
MarketBeat51d ago
MarketBeat51d ago
MarketBeat52d ago
MarketWatch49d ago
MarketBeat49d ago
MarketWatch52d ago
GuruFocus52d ago
Yahoo Finance52d ago
MarketBeat52d ago
Loading more...